Compare Pfizer with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs J.B.CHEMICALS - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER J.B.CHEMICALS PFIZER/
J.B.CHEMICALS
 
P/E (TTM) x 33.0 16.3 201.7% View Chart
P/BV x 5.5 2.3 244.8% View Chart
Dividend Yield % 0.6 0.5 118.4%  

Financials

 PFIZER   J.B.CHEMICALS
EQUITY SHARE DATA
    PFIZER
Mar-18
J.B.CHEMICALS
Mar-18
PFIZER/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs2,365363 651.3%   
Low Rs1,625255 637.3%   
Sales per share (Unadj.) Rs430.3169.1 254.4%  
Earnings per share (Unadj.) Rs78.716.6 474.1%  
Cash flow per share (Unadj.) Rs93.223.4 397.9%  
Dividends per share (Unadj.) Rs20.002.00 1,000.0%  
Dividend yield (eoy) %1.00.6 154.9%  
Book value per share (Unadj.) Rs586.5172.5 340.0%  
Shares outstanding (eoy) m45.7583.57 54.7%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.61.8 253.8%   
Avg P/E ratio x25.318.6 136.1%  
P/CF ratio (eoy) x21.413.2 162.2%  
Price / Book Value ratio x3.41.8 189.9%  
Dividend payout %25.412.0 210.9%   
Avg Mkt Cap Rs m91,27125,827 353.4%   
No. of employees `0002.63.8 69.7%   
Total wages/salary Rs m3,1432,511 125.2%   
Avg. sales/employee Rs Th7,484.83,747.4 199.7%   
Avg. wages/employee Rs Th1,195.0665.7 179.5%   
Avg. net profit/employee Rs Th1,369.1367.8 372.3%   
INCOME DATA
Net Sales Rs m19,68514,135 139.3%  
Other income Rs m1,143366 312.4%   
Total revenues Rs m20,82814,501 143.6%   
Gross profit Rs m5,0032,178 229.7%  
Depreciation Rs m663570 116.3%   
Interest Rs m435 12.0%   
Profit before tax Rs m5,4791,940 282.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,878552 340.1%   
Profit after tax Rs m3,6011,387 259.6%  
Gross profit margin %25.415.4 164.9%  
Effective tax rate %34.328.5 120.4%   
Net profit margin %18.39.8 186.4%  
BALANCE SHEET DATA
Current assets Rs m24,16710,470 230.8%   
Current liabilities Rs m9,5442,749 347.2%   
Net working cap to sales %74.354.6 136.0%  
Current ratio x2.53.8 66.5%  
Inventory Days Days5555 99.8%  
Debtors Days Days2978 37.0%  
Net fixed assets Rs m9,5145,811 163.7%   
Share capital Rs m458167 273.8%   
"Free" reserves Rs m26,37514,248 185.1%   
Net worth Rs m26,83214,416 186.1%   
Long term debt Rs m250-   
Total assets Rs m36,90017,649 209.1%  
Interest coverage x1,305.556.6 2,307.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.8 66.6%   
Return on assets %9.88.1 121.2%  
Return on equity %13.49.6 139.5%  
Return on capital %20.413.7 149.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m226,164 0.4%   
Fx outflow Rs m1,4891,334 111.6%   
Net fx Rs m-1,4664,829 -30.4%   
CASH FLOW
From Operations Rs m3,3181,231 269.6%  
From Investments Rs m-2,383-208 1,145.1%  
From Financial Activity Rs m-1,104-595 185.4%  
Net Cashflow Rs m-169427 -39.5%  

Share Holding

Indian Promoters % 0.0 55.4 -  
Foreign collaborators % 63.9 0.3 21,300.0%  
Indian inst/Mut Fund % 7.5 3.4 221.2%  
FIIs % 4.9 3.9 125.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 37.0 64.1%  
Shareholders   85,207 30,437 279.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   GSK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  STERLING BIOTECH  JUBILANT LIFE SCIENCES  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps 470 Points; Energy and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended deep in the red. The BSE Sensex fell over 550 points intraday and breached the 36,000 mark.

Related Views on News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Sep 19, 2019 (Close)

TRACK PFIZER

PFIZER - UNICHEM LAB COMPARISON

COMPARE PFIZER WITH

MARKET STATS